Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD-404 Phase I/II Study in Healthy Adult Males
jRCT2080224115Phase 2Completed
- Sponsor
- KM Biologics
- Start
- Oct 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of KD-404 in influenza (4 arms), sponsored by KM Biologics. Primary endpoint: Safety and tolerability of KD-404. Started Oct 2018; status: completed.
02
Drugs
KD-404
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080224115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224115.